Skip to content
pitch

UPC Case Law

Boehringer Ingelheim International GmbH v Zentiva Portugal, LDA.

Order of the UPC Court of Appeal of 13 August 2025, UPC CoA 446/2025

UPC Case Law by Pitch, edited by Bart Lieben · Published

TL;DR

The Court of Appeal granted Boehringer Ingelheim a provisional injunction against Zentiva's nintedanib generics in all 17 UPC states where EP 1 830 843 is in force. It held that completing Portugal's pricing and reimbursement procedure more than a year before patent expiry amounted to an imminent infringement. Generics companies that clear national price and reimbursement steps early now face pre-launch injunctions even before any offer is made.

Key holding

Under Art 62(1) and (4) UPCA and R 206.2(c) RoP, an infringement is imminent where the potential infringer has set the stage, so that infringement is only a matter of starting the action because preparations are fully completed. Applying for or obtaining a marketing authorisation for a generic medicine does not by itself create an imminent infringement. Completing the national procedures for health technology assessment, pricing and reimbursement can do so, assessed against the national regulatory context and the circumstances of the case. Taking part in public procurement with an infringing product is 'offering' under Art 25 UPCA, whether or not national law classifies the procedure as pre-contractual.

Questions decided

  1. Does applying for or obtaining a marketing authorisation for a generic amount to imminent infringement?
  2. Can completing pricing and reimbursement procedures amount to imminent infringement?
  3. Is participation in public procurement 'offering' under Art 25 UPCA?
  4. Should the draft EU pharma Bolar provision shape the imminence test?
  5. Can an information order under Art 67 UPCA be granted for a merely imminent infringement?
  6. Who must prove the content of national law under Art 24 UPCA?

Full summary

Read the full analyses for free — create a free account

With a free Academy account you read the full analysis of every Court of Appeal decision: the facts and procedure, the issues, the court’s reasoning and the practice points. Your name, an e-mail address and a password; no payment, and you can delete the account yourself at any time.

Create an account

At least 12 characters. A few words in a row make a strong password that’s easy to remember.

Already have an account?

In the same case

More on provisional measures

Provisional measures →

← All Court of Appeal summaries

Let’s talk

Tell us what you’re working on. We’ll get the right person on it and reply within one business day. The first chat is free.

Schedule a meeting